// App-Quantinova.ai

SUN-745 : Pegaspargase: A Rare but Dangerous Cause of Diabetic Ketoacidosis

Researchers

Presenter

  • Monica Shah

Principal Investigators

  • N/A

Medical Centers

  • John Stroger Hospital, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Diabetic ketoacidosis

  • Tumor lysis syndrome

  • Acanthosis Nigricans

  • Hyperglycemia

  • Hematology-oncology disease

  • Diabetes

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Hemoglobin A1c

  • White Blood Cell

Drug/Treatment

  • Glucocorticoid

  • Hydrocortisone

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pegaspargase

  • Oncaspar

  • Asparaginase

  • Prednisone

  • Insulin glargine

  • Lispro

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved